Free Trial
OTCMKTS:BMXMF

bioMérieux (BMXMF) Stock Price, News & Analysis

bioMérieux logo
$136.00 0.00 (0.00%)
As of 06/6/2025

About bioMérieux Stock (OTCMKTS:BMXMF)

Key Stats

Today's Range
$136.00
$136.00
50-Day Range
$118.52
$136.00
52-Week Range
$93.50
$136.40
Volume
N/A
Average Volume
1,146 shs
Market Capitalization
$16.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Receive BMXMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for bioMérieux and its competitors with MarketBeat's FREE daily newsletter.

BMXMF Stock News Headlines

Biomerieux SA
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Imagine you're driving down I-45 between Dallas and Houston. You come up behind an 18-wheeler, flick your signal, and accelerate to pass. But when you peak into the cabin of the truck … there's no driver inside! Just a massive rig cruising on its own. Sounds like science fiction? It's already happening.
Kepler Capital Keeps Their Buy Rating on bioMerieux (0RUG)
RBC Capital Sticks to Their Buy Rating for bioMerieux (0RUG)
See More Headlines

BMXMF Stock Analysis - Frequently Asked Questions

bioMérieux's stock was trading at $106.19 at the beginning of 2025. Since then, BMXMF shares have increased by 28.1% and is now trading at $136.00.
View the best growth stocks for 2025 here
.

Shares of BMXMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:BMXMF
CIK
N/A
Employees
14,600
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.98 billion
Cash Flow
$6.02 per share
Price / Cash Flow
22.58
Book Value
$34.31 per share
Price / Book
3.96

Miscellaneous

Free Float
N/A
Market Cap
$16.10 billion
Optionable
Not Optionable
Beta
0.74

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:BMXMF) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners